Morphocell
Company Information
Morphocell Technologies is a regenerative medicine company developing stem cell–derived engineered tissues for severe liver disease and other organ deficiencies. Its platform is based on allogeneic iPSC-derived engineered tissues, and the company’s lead efforts are centered on ReLiver and related approaches to organ replacement therapy. Morphocell positions itself as a preclinical-to-development-stage cell therapy company rather than a conventional small-molecule biotech.
Industry Focus and Technologies
Regenerative medicine, cell therapy, engineered tissues, iPSC-derived therapeutics, organ replacement therapy, liver disease, and tissue engineering.
Location
Laval, Quebec, Canada
Company Size and Stage
Products, Platforms or Focus Areas
ReLiver, allogeneic stem cell-derived engineered tissues, liver-directed regenerative medicine programs, and broader engineered tissue platforms for severe organ deficiencies.